title: Drug-induced lupus associated with infliximab and adalimumab in an adolescent with Crohn disease.
authors.affiliation: Department of Pediatrics, Massachusetts General Hospital, Boston, 02114, USA. gzella@partners.org
authors.forename: Garrett C
authors.initials: GC
authors.lastname: Zella
authors.forename: Michael E
authors.initials: ME
authors.lastname: Weinblatt
authors.forename: Harland S
authors.initials: HS
authors.lastname: Winter
mesh_terms: D000068879:Adalimumab; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069285:Infliximab; D000068879:Adalimumab